Subsequently, we utilized gene expression profiling interaction analysis (GEPIA), the cBio Cancer Genomics Portal (cBioportal), and the Tumor Immune Estimation Resource (TIMER) to assess the expression levels and prognostic significance of EHHADH. The gene discussed is EHHADH; the disease is neoplasm.